Cite
APA Citation
Gengiah, T. N., Abdool Karim, Q., Harkoo, I., Mansoor, L., Zuma, N. Y., Radebe, P., Samsunder, N., Baxter, C., Maharaj, B., Baum, M. M., Moss, J. A., Pozzetto, B., Hankins, C., & Abdool Karim, S. (2022). cAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women. BMJ open, 12(1), . http://access.bl.uk/ark:/81055/vdc_100148628899.0x000023